Immune System News and Research

RSS

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Primary liver cancer is now the second leading cause of cancer-related death worldwide, and its incidences and mortality are increasing rapidly in the United Stated. In late stages of the malignancy, there are no effective treatments or drugs.

14 Nov 2017

Study shows link between psoriasis severity and greater risk of type 2 diabetes

People with psoriasis are at a higher risk to develop type 2 diabetes than those without psoriasis, and the risk increases dramatically based on the severity of the disease.

14 Nov 2017

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

Three physician-researchers with the Children's Center for Cancer and Blood Diseases at Children's Hospital Los Angeles have been awarded more than $1 million in grants from the St. Baldrick's Foundation, the largest private funder of childhood cancer research.

14 Nov 2017

Using AFM to study cancer cells

An interview with Prof. Hermann Schillers, Universität Münster conducted by April Cashin-Garbutt, MA (Cantab).

From Bruker Nano Surfaces and Metrology 14 Nov 2017

Breakthrough discovery could radically change approach to treating Klebsiella infections

Researchers at Queen's University Belfast together with the University of Vienna have discovered that treatment for the antibiotic-resistant bacteria Klebsiella pneumoniae could lie within our bodies' natural defenses.

14 Nov 2017

Anti-parasite drug acts like tailored medicine against colon, prostate cancer

Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.

14 Nov 2017

Absence of VEGF-A in cancer-killing T cells accelerates tumor development

Contrary to what was previously believed, the immune system's cancer-killing T cells are more effective in a tumour's anoxic environment when they have access to growth factor VEGF-A.

13 Nov 2017

Specific way of spelling out genetic code likely allows viruses to evade our cellular defenses

For millions of years, humans and viruses have engaged in a constant tug of war: as our cells evolve new ways to defend us from our viral enemies, these pathogens in turn acquire new traits to sidestep those defenses.

13 Nov 2017

Inflammatory bowel disease patients over the age of 60 often receive older drugs

Inflammatory bowel disease is common amongst older people and there are big differences in the choice of treatment for different age groups. Patients over the age of 60 often receive cortisone drugs instead of more modern medicines that target the immune system.

13 Nov 2017

Dengue immunity can provide protection from subsequent Zika infection

Manifestations of Zika virus (ZIKV) infection differ drastically. Sometimes they are catastrophic, most notably when they cause microcephaly in some babies born to infected mothers.

13 Nov 2017

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Celgene Corporation recently announced results from two phase 3 trials evaluating the efficacy and safety of the drug ozanimod.

10 Nov 2017

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

Researchers at the Icahn School of Medicine at Mount Sinai have created the first mathematical model that can predict how a cancer patient will benefit from certain immunotherapies, according to a study published in Nature.

9 Nov 2017

MGH researchers identify first effective treatment option for autoimmune small-fiber polyneuropathy

An analysis of the medical records of patients treated at Massachusetts General Hospital (MGH) for an often-mysterious condition involving damage to small nerve fibers supports the hypothesis that some cases are caused by autoimmune disease and also identifies the first effective treatment option.

9 Nov 2017

Experimental ‘golden’ potato could hold power to prevent disease in developing nations

An experimental "golden" potato could hold the power to prevent disease and death in developing countries where residents rely heavily upon the starchy food for sustenance, new research suggests.

9 Nov 2017

Researchers catch killer cells red-handed in the act of microbial murder

Immune cells called "killer cells" target bacteria invading the body's cells, but how do they do this so effectively? Bacteria can quickly evolve resistance against antibiotics, yet it seems they have not so readily been able to evade killer cells. This has caused researchers to become interested in finding out the exact mechanism that killer cells use to destroy bacterial invaders.

9 Nov 2017

Researchers find way to improve immunotherapy drugs’ impact while limiting side effects

By connecting highly effective cancer immunotherapy drugs such as anti-CTLA4 (ipilimumab) and anti-PD-L1 (atezolizumab) to peptides that bind to tissues in and around tumors, a research team based at the University of Chicago found a way to improve the drugs' impact while limiting treatment-related side effects.

9 Nov 2017

Injection of nanoparticles could divert immune cells that cause inflammation

A surprise finding suggests that an injection of nanoparticles may be able to help fight the immune system when it goes haywire, researchers at the University of Michigan have shown. The nanoparticles divert immune cells that cause inflammation away from an injury site.

9 Nov 2017

Immune System News and Research

Synthetic double-stranded RNA may have potential for use as vaccine to prevent liver cancer

Study shows link between psoriasis severity and greater risk of type 2 diabetes

CHLA receives more than $1 million from St. Baldrick's Foundation for cancer research

Using AFM to study cancer cells

Breakthrough discovery could radically change approach to treating Klebsiella infections

Anti-parasite drug acts like tailored medicine against colon, prostate cancer

Absence of VEGF-A in cancer-killing T cells accelerates tumor development

Specific way of spelling out genetic code likely allows viruses to evade our cellular defenses

Inflammatory bowel disease patients over the age of 60 often receive older drugs

Dengue immunity can provide protection from subsequent Zika infection

Ozanimod effective against multiple sclerosis, enters New Drug Approval process with FDA

Novel mathematical model can predict how cancer patient will benefit from immunotherapies

MGH researchers identify first effective treatment option for autoimmune small-fiber polyneuropathy

Experimental ‘golden’ potato could hold power to prevent disease in developing nations

Researchers catch killer cells red-handed in the act of microbial murder

Researchers find way to improve immunotherapy drugs’ impact while limiting side effects

Injection of nanoparticles could divert immune cells that cause inflammation

Scientists uncover mechanism that prevents tumor growth in melanoma

Scientists uncover previously unknown mechanism to combat influenza A virus

German scientists develop new nuclear medicine test to identify kidney transplant infection

Understanding the DNA Damage Response in Innate Immunity eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News